Charles River Laboratories CRL Temporary Equity Accretion To Redemption Value
Temporary Equity Accretion To Redemption Value at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityAccretionToRedemptionValue.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's temporary equity accretion to redemption value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's temporary equity accretion to redemption value?
- Charles River Laboratories (CRL) reported temporary equity accretion to redemption value of $3.55M in Q1 2026.
- How has Charles River Laboratories's temporary equity accretion to redemption value changed year-over-year?
- Charles River Laboratories's temporary equity accretion to redemption value increased by 168.8% year-over-year, from $1.32M to $3.55M.
- What does temporary equity accretion to redemption value mean?
- The periodic increase in the recorded value of minority-owned equity to match its potential future payout amount.
- How do you interpret temporary equity accretion to redemption value?
- An increase indicates that the estimated future payout to minority shareholders has grown, potentially due to improved performance of the subsidiary or changes in valuation models.
- How does temporary equity accretion to redemption value compare across companies?
- Common in companies with joint ventures or acquisitions involving earn-outs and put/call options on minority stakes.